Unstable Angina - Disease Information

Overview

Unstable angina (UA) is a type of acute coronary syndrome characterized by new-onset angina, accelerating pattern of previously stable angina, or angina at rest, without evidence of myocardial necrosis. It represents a medical emergency with high risk of progression to myocardial infarction.

Clinical Significance: Unstable angina accounts for approximately 25-30% of acute coronary syndrome presentations. The in-hospital mortality rate is 3-5%, with 10-15% progressing to myocardial infarction within 30 days. Prompt recognition and management are crucial to prevent adverse outcomes.

Classification & Definitions

Braunwald Classification of Unstable Angina:

Class	Definition	Clinical Context	1-Year Mortality
Class I	New onset, severe or accelerated angina No rest pain within 2 months	Primary UA	3-5%
Class II	Angina at rest within past month But not within preceding 48 hours	Subacute rest angina	5-8%
Class III	Angina at rest within 48 hours	Acute rest angina	8-12%

Clinical Subtypes:

Subtype	Characteristics	Mechanism	Frequency
Rest Angina	Pain occurring at rest, >20 minutes duration	Transient coronary occlusion	40-50%
New-onset Angina	Recently developed, progressive symptoms	Rapid plaque progression	20-25%
Crescendo Angina	Previously stable angina becoming more frequent/severe	Plaque instability	30-35%
Post-MI Angina	Angina within 2 weeks of MI	Infarct-related artery reocclusion	5-10%

Pathophysiology

Mechanisms of Plaque Instability:

Plaque Rupture: Thin fibrous cap disruption exposing thrombogenic core
Plaque Erosion: Endothelial denudation with thrombus formation
Intraplaque Hemorrhage: Neovascularization rupture within plaque
Dynamic Obstruction: Coronary vasospasm or constriction
Progressive Mechanical Obstruction: Rapid plaque growth

Thrombotic Cascade in Unstable Angina:

Stage	Pathological Process	Clinical Correlation	Therapeutic Target
1. Plaque Disruption	Fibrous cap rupture/erosion	Angina onset	Statins, anti-inflammatory
2. Platelet Adhesion	vWF-mediated platelet binding	Early symptoms	Aspirin, GP IIb/IIIa inhibitors
3. Platelet Activation	Thromboxane A2, ADP release	Symptom progression	P2Y12 inhibitors
4. Thrombus Formation	Fibrin mesh stabilization	Rest angina	Anticoagulants, fibrinolytics
5. Vasoconstriction	Endothelial dysfunction	Vasospastic component	Nitrates, CCBs

Clinical Presentation

Typical Features:

Pain Character: Similar to stable angina but more intense, prolonged
Duration: Usually 10-20 minutes, may last longer
Precipitants: Often occurs at rest or with minimal exertion
Response to Nitroglycerin: Partial or no relief
Associated Symptoms: Diaphoresis, nausea, dyspnea common

High-Risk Features (TIMI Risk Score):

TIMI Risk Factor	Points	Clinical Significance	14-Day Event Rate
Age ≥65 years	1	Independent predictor	8.3%
≥3 CAD risk factors	1	Atherosclerotic burden	13.2%
Prior coronary stenosis ≥50%	1	Known CAD	16.1%
ST deviation ≥0.5mm	1	Ischemia severity	19.9%
≥2 Anginal episodes in 24h	1	Clinical instability	23.4%
Elevated cardiac markers	1	Necrosis threshold	26.2%
ASA use in past 7 days	1	Aspirin resistance	31.0%

Immediate Emergency Criteria: Hemodynamic instability, acute heart failure, recurrent or ongoing chest pain despite medical therapy, life-threatening arrhythmias, mechanical complications. Require immediate coronary angiography and possible revascularization.

Diagnosis & Risk Stratification

Initial Diagnostic Approach:

Immediate ECG: Within 10 minutes of presentation
Cardiac Biomarkers: Troponin I/T at presentation and 3-6 hours
Risk Stratification: TIMI, GRACE, or HEART score calculation
Bedside Echocardiography: Assess wall motion abnormalities
Continuous Monitoring: ECG monitoring for arrhythmias/ischemia

Diagnostic Criteria for Unstable Angina:

Criterion	Required Findings	Exclusion Criteria
Clinical	Rest angina, new onset, or crescendo pattern	Non-cardiac chest pain
ECG	Transient ST-T changes during pain	Persistent ST elevation (STEMI)
Biomarkers	Normal troponin levels	Elevated troponin (NSTEMI)

Risk Stratification Scores:

Score	Parameters	Risk Categories	Clinical Use
TIMI Risk Score	7 clinical variables	Low (0-2), Intermediate (3-4), High (5-7)	Treatment triage, prognosis
GRACE Risk Score	8 clinical/lab variables	Low (<108), Intermediate (109-140), High (>140)	In-hospital and 6-month mortality
HEART Score	History, ECG, Age, Risk factors, Troponin	Low (0-3), Moderate (4-6), High (7-10)	ED disposition decisions

Acute Management

Immediate Medical Therapy (First 24 hours):

Medication Class	Agent	Dosing	Special Considerations
Antiplatelet	Aspirin	162-325 mg chewed, then 81 mg daily	Absolute contraindication: active bleeding
P2Y12 Inhibitor	Clopidogrel, Ticagrelor, Prasugrel	Loading dose then maintenance	Consider CABG timing with Prasugrel
Anticoagulant	Enoxaparin, UFH, Fondaparinux	Weight-based dosing	Choose based on bleeding risk, strategy
Antianginal	Nitroglycerin	SL 0.4 mg q5min x3, then IV	Avoid with PDE5 inhibitor use
Beta-blocker	Metoprolol	5 mg IV q5min x3, then oral	Caution in heart failure, asthma
Statin	High-intensity statin	Atorvastatin 80 mg	Early initiation, plaque stabilization

Management Strategy Based on Risk:

Risk Category	Initial Management	Invasive Strategy	Timing
Very High Risk	Immediate dual antiplatelet, anticoagulation	Emergency angiography	<2 hours
High Risk	DAPT, anticoagulation, antianginal	Early invasive	<24 hours
Intermediate Risk	Medical therapy, observation	Ischemia-guided	24-72 hours
Low Risk	Medical therapy, stress testing	Conservative	As needed

Ayurvedic Treatment

Ayurvedic Perspective:

Unstable angina is understood as Sannipataja Hritshoola involving all three doshas with predominant Vata and Pitta aggravation. It represents acute Srotorodha (channel obstruction) in Rasavaha and Raktavaha Srotas with Ama (toxins) and Dushti (vitiation) of circulating elements.

Emergency Herbal Interventions:

Arjuna Kwath: Immediate cardiotonic decoction
Hridayarnava Rasa: Emergency formulation for acute cardiac pain
Punarnavadi Guggulu: For associated congestion and edema
Lasunadi Vati: Garlic-based antiplatelet and vasodilator
Sarpagandha Ghan Vati: For hypertension and sympathetic overactivity

Single Herbs for Acute Management:

Herb	Sanskrit Name	Emergency Use	Mechanism of Action
Arjuna	Arjuna (Terminalia arjuna)	Bark decoction every 2-4 hours	Cardioprotective, anti-ischemic, antioxidant
Guggulu	Guggulu (Commiphora mukul)	High dose for plaque stabilization	Anti-inflammatory, lipid-lowering, anti-thrombotic
Garlic	Laśuna (Allium sativum)	Fresh paste or high-potency extract	Antiplatelet, fibrinolytic, vasodilator
Turmeric	Haridrā (Curcuma longa)	High-dose curcumin	Anti-inflammatory, endothelial protection
Ginger	Ārdraka (Zingiber officinale)	Fresh juice with honey	Antiplatelet, anti-inflammatory, vasodilator
Brahmi	Brahmi (Bacopa monnieri)	For anxiety and sympathetic overactivity	Anxiolytic, adaptogen, reduces stress response
Ashwagandha	Aśvagandhā (Withania somnifera)	For stress-induced episodes	Adaptogen, reduces cortisol, cardioprotective

Ayurvedic Emergency Procedures:

Hrid Basti (Emergency): Localized warm oil therapy
- Medicated oils (Mahanarayan, Dhanwantaram)
- Duration: 15-20 minutes during acute episode
- Mechanism: Improves coronary circulation, reduces pain
Shirodhara (Modified): For sympathetic stabilization
- Cooling oils (Brahmi, coconut) for Pitta predominance
- Short duration (10-15 minutes)
- Reduces anxiety and stress response
Pranayama (Emergency): Breathing techniques
- Sheetali and Sheetkari Pranayama for immediate calming
- Anulom Vilom for balancing autonomic nervous system
- Bhramari for anxiety reduction

Dietary Management (Acute Phase):

Immediate Dietary Changes:
- Light, easily digestible foods (moong dal, vegetable soups)
- Warm water or herbal teas throughout day
- Complete avoidance of heavy, fried, processed foods
- Small, frequent meals to avoid gastric pressure on heart
Specific Emergency Nutrition:
- Arjuna bark decoction: 1-2g in warm water every 4-6 hours
- Garlic soup: 3-4 cloves boiled in water with ginger
- Pomegranate juice: Fresh, without sugar
- Coriander seed water: Soaked overnight, strained
Foods to Strictly Avoid:
- Red meat and processed meats
- Fried and fatty foods
- Excess salt and sugar
- Caffeine and stimulants
- Cold drinks and ice cream
- Alcohol and tobacco

Lifestyle Modifications (Acute Phase):

Immediate Rest:
- Complete bed rest for first 48-72 hours
- Semi-Fowler's position (45-degree head elevation)
- Avoid all physical exertion and stress
Stress Management:
- Complete mental rest, avoid emotional triggers
- Meditation and mindfulness techniques
- Soothing music and positive environment
Monitoring:
- Regular pulse monitoring
- Symptom diary for angina episodes
- Blood pressure monitoring if hypertensive

Ayurvedic Emergency Strategy: Immediate approach includes Vatanulomana (Vata pacification) to relieve pain and spasm, Pittashamana (Pitta reduction) to reduce inflammation and thrombotic tendency, Strotoshodhana (channel cleansing) to improve coronary flow, and Rasayana (rejuvenation) for myocardial protection. Integration with conventional emergency care is essential.

Invasive Management

Coronary Angiography Indications:

Scenario	Timing	Expected Findings	Intervention
Refractory angina	Immediate	Critical stenosis, thrombus	PCI with stenting
Hemodynamic instability	Immediate	Left main, multivessel disease	Possible CABG
High TIMI risk (≥5)	<24 hours	Complex lesions	PCI or CABG
Recurrent ischemia	24-72 hours	Progressive disease	Individualized approach

PCI vs CABG Decision Making:

Factor	Favors PCI	Favors CABG
Anatomy	1-2 vessel disease	Left main, multivessel disease
Diabetes	Non-complex lesions	Complex multivessel disease
LV Function	Preserved EF	Reduced EF
Bleeding Risk	Low bleeding risk	High bleeding risk

Complications

Acute Complications:

Complication	Frequency	Risk Factors	Management
Myocardial Infarction	10-15%	High TIMI score, delayed presentation	Emergency revascularization
Arrhythmias	8-12%	Prior MI, electrolyte imbalance	Antiarrhythmics, cardioversion
Heart Failure	5-8%	Multivessel disease, prior dysfunction	Diuretics, afterload reduction
Cardiogenic Shock	2-4%	Extensive ischemia, mechanical complications	Inotropes, mechanical support

Long-term Complications:

Recurrent Ischemia: 15-20% at 6 months
Progression to MI: 5-10% within first year
Heart Failure: 10-15% development over 5 years
Sudden Cardiac Death: 2-3% annual risk

Prognosis & Follow-up

Short-term Outcomes:

Outcome	In-hospital	30-Day	6-Month
Mortality	3-5%	4-6%	6-8%
Myocardial Infarction	8-12%	10-15%	12-18%
Refractory Angina	15-20%	10-15%	8-12%
Revascularization	40-50%	50-60%	60-70%

Follow-up Schedule:

Time Period	Frequency	Key Assessments
First month	Weekly	Symptoms, medication tolerance, risk factors
1-6 months	Every 2-4 weeks	Functional status, medication optimization
6-12 months	Every 3 months	Risk factor control, stress testing if indicated
After 1 year	Every 6-12 months	Comprehensive cardiovascular assessment

Secondary Prevention

Long-term Medical Therapy:

Medication	Duration	Benefit	Monitoring
Dual Antiplatelet Therapy	6-12 months	30-40% event reduction	Bleeding risk assessment
High-intensity Statin	Lifelong	35% event reduction	LDL-C, LFTs
Beta-blocker	Lifelong	25% mortality reduction	Heart rate, BP
ACE Inhibitor	Lifelong	20% event reduction	Creatinine, potassium

Discharge Education Critical Points: Recognize worsening symptoms, medication adherence importance, lifestyle modification, cardiac rehabilitation referral, follow-up appointment scheduling, and when to seek immediate medical attention for recurrent symptoms.